RAPT Therapeutics, Inc. (RAPT) Non-cash Items (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Non-cash Items for 5 consecutive years, with $3000.0 as the latest value for Q3 2024.
- Quarterly Non-cash Items fell 99.95% to $3000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Sep 2024, down 99.95% year-over-year, with the annual reading at $23.2 million for FY2023, 1365.46% up from the prior year.
- Non-cash Items hit $3000.0 in Q3 2024 for RAPT Therapeutics, down from $49000.0 in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $38.4 million in Q4 2021 to a low of $3000.0 in Q3 2024.
- Historically, Non-cash Items has averaged $13.7 million across 5 years, with a median of $11.1 million in 2020.
- Biggest five-year swings in Non-cash Items: skyrocketed 245.38% in 2021 and later plummeted 99.95% in 2024.
- Year by year, Non-cash Items stood at $11.1 million in 2020, then surged by 245.38% to $38.4 million in 2021, then plummeted by 75.47% to $9.4 million in 2022, then skyrocketed by 146.22% to $23.2 million in 2023, then crashed by 99.99% to $3000.0 in 2024.
- Business Quant data shows Non-cash Items for RAPT at $3000.0 in Q3 2024, $49000.0 in Q2 2024, and $1.3 million in Q1 2024.